Skip to main content

Table 2 Mortality by comorbidity

From: Does comorbidity explain the ethnic inequalities in cervical cancer survival in New Zealand? A retrospective cohort study

Comorbidity

HR (95%CI)a

Cervical cancer

Elixhauser (1 unit)

1.25 (1.11-1.40)

Elixhauser 0

1.00b

Elixhauser 1

1.29 (0.96-1.75)

Elixhauser 2

1.33 (0.83-2.13)

Elixhauser 3+

2.17 (1.32-3.56)

Other mortality (not cervical cancer)

Elixhauser (1 unit)

1.46 (1.18-1.79)

Elixhauser 0

1.00b

Elixhauser 1

2.49 (1.39-4.44)

Elixhauser 2

2.62 (1.20-5.72)

Elixhauser 3+

2.76 (1.04-7.30)

Total mortality

Elixhauser (1 unit)

1.28 (1.15-1.41)

Elixhauser 0

1.00b

Elixhauser 1

1.47 (1.13-1.92)

Elixhauser 2

1.48 (0.99-2.21)

Elixhauser 3+

2.20 (1.41-3.41)

  1. a Adjusted for age, year of diagnosis, stage, ethnicity, socioeconomic position, and urban/rural residence
  2. b Reference category